Acute renal failure after treatment with sunitinib in a patient with multiple myeloma

Nelson Leung1, Nathan A Saucier1, Steven R Zeldenrust2

  • 1Division of Nephrology and Hypertension.

NDT Plus
|May 19, 2015
PubMed

Insights

Sunitinib, a cancer drug, can cause kidney damage. This report details the first case of acute tubular necrosis, a severe kidney injury, in a multiple myeloma patient treated with sunitinib.

Area of Science:

  • Nephrology
  • Oncology
  • Pharmacology

Background:

  • Sunitinib is an oral multi-targeted tyrosine kinase inhibitor approved for advanced renal cell carcinoma.
  • Its known targets include fetal liver tyrosine kinase receptor 3 (FLT3) and vascular endothelial growth factor receptor (VEGFR).
  • While clinical trials did not report renal toxicity, some patients developed a pre-eclampsia-like syndrome.

Observation:

  • A patient with multiple myeloma was treated with sunitinib.
  • The patient developed acute tubular necrosis.

Findings:

  • This is the first reported case of acute tubular necrosis in a multiple myeloma patient receiving sunitinib.
  • The mechanism linking sunitinib to acute tubular necrosis in this context requires further investigation.

Implications:

  • This case highlights a potential, previously unreported renal adverse effect of sunitinib.
  • Clinicians should be vigilant for renal toxicity, including acute tubular necrosis, in multiple myeloma patients treated with sunitinib.
  • Further research is warranted to elucidate the pathophysiology and incidence of sunitinib-induced acute tubular necrosis.

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
602
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.5K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
515
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
2.1K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
835
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
591